CN106822726A - 一种治疗淋巴结核的膏药及其制备方法 - Google Patents
一种治疗淋巴结核的膏药及其制备方法 Download PDFInfo
- Publication number
- CN106822726A CN106822726A CN201710162384.0A CN201710162384A CN106822726A CN 106822726 A CN106822726 A CN 106822726A CN 201710162384 A CN201710162384 A CN 201710162384A CN 106822726 A CN106822726 A CN 106822726A
- Authority
- CN
- China
- Prior art keywords
- parts
- fresh
- plaster
- traditional chinese
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000011505 plaster Substances 0.000 title claims abstract description 55
- 238000002360 preparation method Methods 0.000 title claims description 7
- 239000003814 drug Substances 0.000 claims abstract description 46
- 239000000843 powder Substances 0.000 claims abstract description 42
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 29
- 241000427250 Moehringia Species 0.000 claims abstract description 26
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 20
- 239000006071 cream Substances 0.000 claims abstract description 20
- 241001082427 Euphorbia lunulata Species 0.000 claims abstract description 11
- 235000014676 Phragmites communis Nutrition 0.000 claims abstract description 11
- 241000985694 Polypodiopsida Species 0.000 claims abstract description 11
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 11
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 11
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000010931 gold Substances 0.000 claims abstract description 11
- 229910052737 gold Inorganic materials 0.000 claims abstract description 11
- 235000008113 selfheal Nutrition 0.000 claims abstract description 11
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 10
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 10
- 239000011718 vitamin C Substances 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 244000234609 Portulaca oleracea Species 0.000 claims abstract 3
- 241001494479 Pecora Species 0.000 claims description 22
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 18
- 239000000758 substrate Substances 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 11
- XUBKCCSAVNRWOX-BVHPQESASA-N rifandin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C(O)=C4C)C)OC)C4=C1C3=C(O)C=2N1CCN(CC(C)C)CC1 XUBKCCSAVNRWOX-BVHPQESASA-N 0.000 claims description 10
- 229930003427 Vitamin E Natural products 0.000 claims description 9
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 9
- 235000019165 vitamin E Nutrition 0.000 claims description 9
- 229940046009 vitamin E Drugs 0.000 claims description 9
- 239000011709 vitamin E Substances 0.000 claims description 9
- 241000258920 Chilopoda Species 0.000 claims description 7
- 241000576429 Forsythia suspensa Species 0.000 claims description 7
- 241001547125 Fritillaria thunbergii Species 0.000 claims description 7
- 241000219745 Lupinus Species 0.000 claims description 7
- 244000241872 Lycium chinense Species 0.000 claims description 7
- 235000015468 Lycium chinense Nutrition 0.000 claims description 7
- 241001050782 Patrinia heterophylla Species 0.000 claims description 7
- VRDIULHPQTYCLN-UHFFFAOYSA-N Prothionamide Chemical compound CCCC1=CC(C(N)=S)=CC=N1 VRDIULHPQTYCLN-UHFFFAOYSA-N 0.000 claims description 7
- 241000522620 Scorpio Species 0.000 claims description 7
- 241001671204 Stemona Species 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 7
- 229960000918 protionamide Drugs 0.000 claims description 7
- 239000009490 scorpio Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 6
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 6
- 244000025254 Cannabis sativa Species 0.000 claims description 6
- 210000000941 bile Anatomy 0.000 claims description 6
- 229940116229 borneol Drugs 0.000 claims description 6
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 6
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 6
- 235000012907 honey Nutrition 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims description 3
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims description 3
- 244000145469 Vernonia anthelmintica Species 0.000 claims description 3
- 235000013018 Vernonia anthelmintica Nutrition 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000004745 nonwoven fabric Substances 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims description 3
- 241001522129 Pinellia Species 0.000 claims 2
- 241000256844 Apis mellifera Species 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 201000007227 lymph node tuberculosis Diseases 0.000 abstract description 13
- 208000024891 symptom Diseases 0.000 abstract description 11
- 201000008827 tuberculosis Diseases 0.000 abstract description 11
- 206010029410 night sweats Diseases 0.000 abstract description 5
- 230000036565 night sweats Effects 0.000 abstract description 5
- 230000036528 appetite Effects 0.000 abstract description 4
- 235000019789 appetite Nutrition 0.000 abstract description 4
- 230000003902 lesion Effects 0.000 abstract description 3
- 241000219304 Portulacaceae Species 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 230000035876 healing Effects 0.000 description 6
- 210000001165 lymph node Anatomy 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 241000489492 Arisaema Species 0.000 description 5
- 208000025865 Ulcer Diseases 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 230000000202 analgesic effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 241000238557 Decapoda Species 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- GSFDOOHGKOHDEL-UHFFFAOYSA-N Dalpanitin Natural products COc1cc(ccc1O)C2=COc3c(C4OC(CO)C(O)C(O)C4O)c(O)cc(O)c3C2=O GSFDOOHGKOHDEL-UHFFFAOYSA-N 0.000 description 2
- 206010016717 Fistula Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- YXHFXGHAELQJGK-PGPONNFDSA-N Scoparin Chemical compound C1=C(O)C(OC)=CC(C=2OC3=C([C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)C(O)=CC(O)=C3C(=O)C=2)=C1 YXHFXGHAELQJGK-PGPONNFDSA-N 0.000 description 2
- RTRPDMVGOFRVOY-UHFFFAOYSA-N Scoparin Natural products COc1cc(ccc1O)C2=CC(=O)c3c(O)cc(O)c(OC4OC(CO)C(O)C(O)C4O)c3O2 RTRPDMVGOFRVOY-UHFFFAOYSA-N 0.000 description 2
- 230000001663 anti-spastic effect Effects 0.000 description 2
- 230000002365 anti-tubercular Effects 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003890 fistula Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 229960003350 isoniazid Drugs 0.000 description 2
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000002751 lymph Anatomy 0.000 description 2
- 230000001926 lymphatic effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical group C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- WISOACODKWCRQK-UHFFFAOYSA-N (-)-5alpha,8alpha-Epidioxycholesta-6,22-dien-3beta-ol Natural products O1OC2(C=C3)C4CCC(C(C)C=CCC(C)C)C4(C)CCC2C2(C)C13CC(O)CC2 WISOACODKWCRQK-UHFFFAOYSA-N 0.000 description 1
- -1 22,23- dihydro spinasterol palmitates Chemical class 0.000 description 1
- HRGUSFBJBOKSML-UHFFFAOYSA-N 3',5'-di-O-methyltricetin Chemical compound COC1=C(O)C(OC)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 HRGUSFBJBOKSML-UHFFFAOYSA-N 0.000 description 1
- CHQBGSRZQLMDEX-UHFFFAOYSA-N 9h-pyrido[3,4-b]indole-1-carbaldehyde Chemical compound C12=CC=CC=C2NC2=C1C=CN=C2C=O CHQBGSRZQLMDEX-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 102000001621 Mucoproteins Human genes 0.000 description 1
- 108010093825 Mucoproteins Proteins 0.000 description 1
- 241000158526 Nasalis Species 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- IDDMFNIRSJVBHE-UHFFFAOYSA-N Piscigenin Natural products COC1=C(O)C(OC)=CC(C=2C(C3=C(O)C=C(O)C=C3OC=2)=O)=C1 IDDMFNIRSJVBHE-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- YSKVBPGQYRAUQO-UHFFFAOYSA-N Schottenol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CCC21 YSKVBPGQYRAUQO-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- 239000003809 bile pigment Substances 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
- VXOZCESVZIRHCJ-KGHQQZOUSA-N ergosterol peroxide Chemical compound O1O[C@@]2(C=C3)[C@@H]4CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]4(C)CC[C@@H]2[C@]2(C)[C@@]13C[C@@H](O)CC2 VXOZCESVZIRHCJ-KGHQQZOUSA-N 0.000 description 1
- VXOZCESVZIRHCJ-KYQKSOQPSA-N ergosterol peroxide Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@@H]2[C@]1(C)CC[C@@H]3[C@@]4(C)CC[C@H](O)C[C@@]45OO[C@@]23C=C5 VXOZCESVZIRHCJ-KYQKSOQPSA-N 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 150000002561 ketenes Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 231100000057 systemic toxicity Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- BMCJATLPEJCACU-UHFFFAOYSA-N tricin Natural products COc1cc(OC)c(O)c(c1)C2=CC(=O)c3c(O)cc(O)cc3O2 BMCJATLPEJCACU-UHFFFAOYSA-N 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/413—Gall bladder; Bile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Insects & Arthropods (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Animal Husbandry (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及以一种治疗淋巴结核的膏药,属于中西药结合技术领域。一种治疗淋巴结核的膏药,由以下按重量份配比的原料制成:胆膏18‑32份、雪灵芝22‑40份、乙醇33‑50份、鲜夏枯草6‑10份、鲜猫眼草3‑8份、鲜马齿苋5‑9份、鲜小果蕗蕨2‑7份、鲜女金芦4‑8份、中药粉8‑25份、中药稠膏11‑26份、维生素C 1‑3份。本发明的一种治疗淋巴结核的膏药,采用对病患处外敷方式,可以有效的控制结核的生长以及病变,并且还可以有效的预防由于淋巴结核所产生的低热、盗汗、食欲不振等症状。
Description
技术领域
本发明涉及以一种治疗淋巴结核的膏药及其制备方法,属于中西药结合技术领域。
背景技术
淋巴结核,中医称之为瘰疬,是体现于肌表的毒块组织,是由肝肺两方面的痰毒热毒凝聚所成。西医则指,人体内有专事于清毒杀毒从而保护血管,组织的淋巴系统,遭遇来自体内外无法清除杀灭的毒菌,凝聚和集结于肌表组织形成的毒瘤。多在颈部一侧或双侧长出疙瘩,逐渐长大,不痛不痒,推入滑动,无明显压痛,如身体抵抗力低则逐渐增大,皮肤发变紫,最终破溃流水样脓液并排出黄浊样干酪样脓液,中医称之谓“老鼠疮”。反复溃烂少,部分病人可有低热、盗、汗食欲不振、消瘦等全身中毒症状。淋巴结结核发病原因有两种:一种是结核杆菌通过上呼吸道或随食物在口腔及鼻咽部尤其是扁桃体腺引起的原发灶上感染。后沿淋巴管到达颈部浅深层淋巴结。各部位多为单侧性淋巴结。受累咽部。重发病以上吸收后受累淋巴结核仍继续发展形成冷脓肿或溃疡。另一种是原发结核感染后血中结核杆菌随血行进入内侧颈淋巴结,引起颈淋巴结核;还可以从腰腹部淋巴感染,然后汲及深部淋巴结群继发感染,在颈淋巴结结核发病中较为常见。目前的治疗方法在西医领域主要采用手术方式,在中医方面主要采用针灸或中药汤剂内消,但不管哪种方法,都非常容易复发,而且在用药方面还会有副作用,因此外敷方式是一种选择。
发明内容
本发明的目的在于解决上述已有技术存在的不足之处,提供一种配伍合理、使用方面、无毒副作用的治疗淋巴结核的膏药及其制备方法。
本发明是通过以下技术方案实现的:
一种治疗淋巴结核的膏药,其特殊之处在于由以下按重量份配比的原料制成:羊胆膏18-32份、雪灵芝22-40份、乙醇33-50份、鲜夏枯草6-10份、鲜猫眼草3-8份、鲜马齿苋5-9份、鲜小果蕗蕨2-7份、鲜女金芦4-8份、中药粉8-25份、中药稠膏11-26份、维生素C 1-3份、维生素E 0.8-1.6份、异丁哌利福霉素2-5份、丙硫异烟胺片1-5份、尼泊金丙酯3-6份、膏药基质134-260份;
进一步的,羊胆膏是由羊胆汁、蜂蜜、冰片粉按5:10:1的比例混合熬制而成;
进一步的,乙醇浓度为80%;
进一步的,中药粉是由蜈蚣、全蝎、浙贝母按1:1:2的比例混合制成;
进一步的,中药稠膏是由墓头回、母猪半夏、玄参、连翘、泽泻、地骨皮、山橙、野火球、咸虾花、百部按各10%的质量份数混合熬制而成;
进一步的,膏药基质为松香膏药基质;
所述一种治疗淋巴结核的膏药,由以下按重量份最优配比的原料制成:羊胆膏25份、雪灵芝32份、乙醇41份、鲜夏枯草8份、鲜猫眼草5份、鲜马齿苋7份、鲜小果蕗蕨5份、鲜女金芦6份、中药粉14份、中药稠膏20份、维生素C 2份、维生素E 1.2份、异丁哌利福霉素3份、丙硫异烟胺片3份、尼泊金丙酯5份、膏药基质223份;
一种治疗淋巴结核的膏药的制备方法,其特殊之处在于包括以下步骤:
(1)取3/4的雪灵芝,切成碎粒,加入到乙醇中浸泡32-48小时,渗漉,得到初漉液,减压回收乙醇,浓缩至干,研磨粉碎,过80-120目筛子,得到雪灵芝渗漉粉;
(2)将剩余1/4的雪灵芝研磨粉碎,过80-120目筛子,得到雪灵芝研磨粉;
(3)将鲜夏枯草、鲜猫眼草、鲜马齿苋、鲜小果蕗蕨、鲜女金芦分别清洗干净、打成泥,混合、搅拌均匀,得到鲜草泥;
(4)将维生素C、维生素E、异丁哌利福霉素、丙硫异烟胺片分别研磨成超微粉末,混合,过200-300目筛子,得到西药粉;
(5)将膏药基质加热至65-75℃,拌入雪灵芝渗漉粉、雪灵芝研磨粉、中药粉和西药粉,搅拌均匀,自然冷却至40-50℃,拌入羊胆膏和中药稠膏,搅拌均匀,再自然冷却至20-30℃,加入鲜草泥、尼泊金丙酯,搅拌均匀,得到膏药糊;
(6)将步骤(5)的膏药糊涂在无纺布上,并盖上PE膜,裁剪成需要的规格即可。
优选的,羊胆膏是由羊胆汁加入蜂蜜,文火熬制成膏,再拌入冰片粉,搅拌均匀,即可;
优选的,中药粉是将蜈蚣、全蝎、浙贝母按比例称好、清洗干净、烘干,分别研磨成100-120目粉末,混合而成;
优选的,中药稠膏是将墓头回、母猪半夏、玄参、连翘、泽泻、地骨皮、山橙、野火球、咸虾花、百部按量称好,加入5-8倍的水煎煮2-4小时,过滤、浓缩至稠膏状,即可。
各中药组分的功效:
雪灵芝:全草含生物碱:蚤缀碱A、B、C、D和1-乙酸基-β-咔啉,l-甲氧甲酸基-β-咔啉;甾体裁成分:22,23-二氢菠菜甾醇,22,23-二氢菠菜甾酮,麦角甾醇-5,8-过氧化物,24-亚甲基-22,23-二氢羊毛甾醇,羊齿烯酮,胡萝卜甙,22,23-二氢菠菜甾醇棕榈酸酯;以及黄酮类成分:小麦黄素,右旋异金雀花素和左旋异金雀花素。具有清热解毒、利胆退黄、通淋止痛等功效,对淋巴结核具有抑制作用。
羊胆膏:主要成分有胆汁酸盐、胆色素(主为胆红素和胆绿紊)、粘蛋白、胆甾醇、卵磷脂、碳酸氢钠等,具有清热解毒、明目退翳等功效,可以缓解淋巴结核所引起的症状;
夏枯草:主要功效是清热泻火、明目、散结消肿,对淋巴结核有治愈作用;
猫眼草:主要功效是败毒抗癌、逐痰散结,对淋巴结核有治愈作用;
马齿苋:主要功效是清热利湿、解毒消肿、消炎,对淋巴结核有治愈作用;
小果蕗蕨:主要功效是清热解毒、敛疮生肌,可以缓解淋巴结核的症状;
女金芦:主要功效是清热解毒、消食导滞、舒筋活络,可以缓解淋巴结核的症状;
蜈蚣:主要功效是息风镇痉,功毒散结,通络止痛,可以起到抗菌止痛的作用,有利于淋巴结核的消散和恢复;
全蝎:主要功效是息风镇痉、通络止痛、攻毒散结,可以起到镇痛散结的作用,有利于淋巴结核的消散和恢复;
浙贝母:主要功效是清热化痰、散结解毒,可以起到消肿的作用,有利于淋巴结核的消散和恢复;
墓头回:主要功效是燥湿止带、收敛止血、清热解毒;
母猪半夏:主要功效是散瘀、解毒、止痛;
玄参:主要功效是清热凉血、滋阴降火、解毒散结;
连翘:主要功效是清热解毒、散结消肿;
泽泻:主要功效是利水、渗湿、泄热;
地骨皮:主要功效是清热、凉血;
山橙:主要功效是行气、止痛、除湿、杀虫;
野火球:主要功效是止咳、镇痛、散结;
咸虾花:主要功效是清热利湿、散瘀消肿;
百部:主要功效是散热解表;
维生素C:主要起到抗氧化、抗炎的作用,可以进一步的,可以进一步深化药物的消肿和抗炎功效;
维生素E:主要用于改善微循环,使末梢血管扩张,改善血液循环,更有利于药物的吸收;
异丁哌利福霉素:属于抗结核药物,在与其他药物成分的相互作用,可以有效的用于结核病的初始和复发;
丙硫异烟胺片:属于抗结核药物,在与其他药物成分的相互作用,可以进一步治疗药物无效者;
本发明的一种治疗淋巴结核的膏药,采用对病患处外敷方式,可以有效的控制结核的生长以及病变,并且还可以有效的预防由于淋巴结核所产生的低热、盗汗、食欲不振等症状。 各中药组分配伍合理,协同增效,还具有软化和保护皮肤的作用,使用简便,成本低,治疗效果显著。
具体实施方式
以下给出本发明的具体实施方式,用来对本发明的构成作进一步详细说明。
实施例1
本实施例的一种治疗淋巴结核的膏药,由以下按重量份配比的原料制成:羊胆膏18份、雪灵芝22份、乙醇33份、鲜夏枯草6份、鲜猫眼草3份、鲜马齿苋5份、鲜小果蕗蕨2份、鲜女金芦4份、中药粉8份、中药稠膏11份、维生素C 1份、维生素E 0.8份、异丁哌利福霉素2份、丙硫异烟胺片1份、尼泊金丙酯3份、膏药基质134份;其中羊胆膏是由羊胆汁、蜂蜜、冰片粉按5:10:1的比例混合熬制而成;乙醇浓度为80%;中药粉是由蜈蚣、全蝎、浙贝母按1:1:2的比例混合制成;中药稠膏是由墓头回、母猪半夏、玄参、连翘、泽泻、地骨皮、山橙、野火球、咸虾花、百部按各10%的质量份数混合熬制而成;膏药基质为松香膏药基质。
实施例2
本实施例的一种治疗淋巴结核的膏药,由以下按重量份配比的原料制成:羊胆膏32份、雪灵芝40份、乙醇50份、鲜夏枯草10份、鲜猫眼草8份、鲜马齿苋9份、鲜小果蕗蕨7份、鲜女金芦8份、中药粉25份、中药稠膏26份、维生素C3份、维生素E 1.6份、异丁哌利福霉素5份、丙硫异烟胺片5份、尼泊金丙酯6份、膏药基质260份。
实施例3
本实施例的一种治疗淋巴结核的膏药,由以下按重量份最优配比的原料制成:羊胆膏25份、雪灵芝32份、乙醇41份、鲜夏枯草8份、鲜猫眼草5份、鲜马齿苋7份、鲜小果蕗蕨5份、鲜女金芦6份、中药粉14份、中药稠膏20份、维生素C2份、维生素E 1.2份、异丁哌利福霉素3份、丙硫异烟胺片3份、尼泊金丙酯5份、膏药基质223份。
以上实施例的一种治疗淋巴结核的膏药的制备方法,包括以下步骤:
(1)取3/4的雪灵芝,切成碎粒,加入到乙醇中浸泡42小时,渗漉,得到初漉液,减压回收乙醇,浓缩至干,研磨粉碎,过100目筛子,得到雪灵芝渗漉粉;
(2)将剩余1/4的雪灵芝研磨粉碎,过100目筛子,得到雪灵芝研磨粉;
(3)将鲜夏枯草、鲜猫眼草、鲜马齿苋、鲜小果蕗蕨、鲜女金芦分别清洗干净、打成泥,混合、搅拌均匀,得到鲜草泥;
(4)将维生素C、维生素E、异丁哌利福霉素、丙硫异烟胺片分别研磨成超微粉末,混合,过250目筛子,得到西药粉;
(5)将膏药基质加热至70℃,拌入雪灵芝渗漉粉、雪灵芝研磨粉、中药粉和西药粉,搅拌均匀,自然冷却至45℃,拌入羊胆膏和中药稠膏,搅拌均匀,再自然冷却至25℃,加入鲜草泥、尼泊金丙酯,搅拌均匀,得到膏药糊;
(6)将步骤(5)的膏药糊涂在无纺布上,并盖上PE膜,裁剪成需要的规格即可。
优选的,羊胆膏是由羊胆汁加入蜂蜜,文火熬制成膏,再拌入冰片粉,搅拌均匀,即可;
优选的,中药粉是将蜈蚣、全蝎、浙贝母按比例称好、清洗干净、烘干,分别研磨成110目粉末,混合而成;
优选的,中药稠膏是将墓头回、母猪半夏、玄参、连翘、泽泻、地骨皮、山橙、野火球、咸虾花、百部按量称好,加入7倍的水煎煮3小时,过滤、浓缩至稠膏状,即可。
以上实施例的一种治疗淋巴结核的膏药,本发明的一种治疗淋巴结核的膏药,采用对病患处外敷方式,可以有效的控制结核的生长以及病变,并且还可以有效的预防由于淋巴结核所产生的低热、盗汗、食欲不振等症状。
下面列举6个典型的临床病例,用以说明使用本发明的膏药后,症状明显消失,治疗效果好,不复发:
病例一:王某,男,32岁,山东人,诊断为颈部淋巴结核,发病时长为3个月,颈部后部有数枚手指大小肿块,伴有盗汗症状,未溃烂,使用本发明的膏药外敷1个星期,症状消失,半年后复查,无复发。
病例2:张某某,男,35岁,河南人,诊断为颈部淋巴结核,发病时长2年,颈部两侧后方有成串肿块,患病处脓肿溃烂,伴有精神倦怠、失眠、腹胀的症状, 使用本发明的膏药1个月,症状缓解,溃疡消失,使用2个月肿胀消失,至今无复发。
病例3:匡某,女,52岁,宁夏人,诊断为腋窝部淋巴结核,发病时长4个月,腋窝处淋巴结肿大,伴有疼痛,无溃烂,使用本发明的膏药1个月,疼痛消失,肿胀消退,3个月后复查,无复发。
病例4:刘某某,男,41岁,北京人,诊断为腹股沟淋巴结核,发病时长8个月,腹股沟处有大小不同的多处肿胀,并有少量的穿溃脓血,使用本发明的膏药,1个月,溃烂愈合,1个半月,肿胀消散,半年后复查,无复发。
病例5:张某,女,50岁,北京人,诊断为腹部淋巴结核,发病时长1年,为术后刀口不愈合,后溃疡化脓,形成瘘孔,使用本发明的膏药,2个月后,溃疡消失,3个月后瘘孔愈合,至今再无复发。
病例6:闵某某,男,51岁,吉林人,诊断为肺门淋巴结核,发病时长1年零2个月,X射线显示双侧肺门阴影增大,伴有咳嗽咳痰、盗汗、乏力,使用本发明的膏药2个月后复查,肺门阴影消失,其他症状消退,3个月后复查,无复发。
Claims (10)
1.一种治疗淋巴结核的膏药,其特征在于由以下按重量份配比的原料制成:羊胆膏18-32份、雪灵芝22-40份、乙醇33-50份、鲜夏枯草6-10份、鲜猫眼草3-8份、鲜马齿苋5-9份、鲜小果蕗蕨2-7份、鲜女金芦4-8份、中药粉8-25份、中药稠膏11-26份、维生素C 1-3份、维生素E 0.8-1.6份、异丁哌利福霉素2-5份、丙硫异烟胺片1-5份、尼泊金丙酯3-6份、膏药基质134-260份。
2.根据权利要求1所述一种治疗淋巴结核的膏药,其特征在于羊胆膏是由羊胆汁、蜂蜜、冰片粉按5:10:1的比例混合熬制而成。
3.根据权利要求1所述一种治疗淋巴结核的膏药,其特征在于乙醇浓度为80%。
4.根据权利要求1所述一种治疗淋巴结核的膏药,其特征在于中药粉是由蜈蚣、全蝎、浙贝母按1:1:2的比例混合制成。
5.根据权利要求1所述一种治疗淋巴结核的膏药,其特征在于中药稠膏是由墓头回、母猪半夏、玄参、连翘、泽泻、地骨皮、山橙、野火球、咸虾花、百部按各10%的质量份数混合熬制而成。
6.根据权利要求1所述一种治疗淋巴结核的膏药,其特征在于由膏药基质为松香膏药基质。
7.根据权利要求2所述一种治疗淋巴结核的膏药,其特征在于羊胆膏是由羊胆汁加入蜂蜜,文火熬制成膏,再拌入冰片粉,搅拌均匀,即可。
8.根据权利要求4所述一种治疗淋巴结核的膏药,其特征在于中药粉是将蜈蚣、全蝎、浙贝母按比例称好、清洗干净、烘干,分别研磨成100-120目粉末,混合而成。
9.根据权利要求5所述一种治疗淋巴结核的膏药,其特征在于中药稠膏是将墓头回、母猪半夏、玄参、连翘、泽泻、地骨皮、山橙、野火球、咸虾花、百部按量称好,加入5-8倍的水煎煮2-4小时,过滤、浓缩至稠膏状,即可。
10.权利要求1-9所述一种治疗淋巴结核的膏药的制备方法,其特征在于包括以下步骤:
(1)取3/4的雪灵芝,切成碎粒,加入到乙醇中浸泡32-48小时,渗漉,得到初漉液,减压回收乙醇,浓缩至干,研磨粉碎,过80-120目筛子,得到雪灵芝渗漉粉;
(2)将剩余1/4的雪灵芝研磨粉碎,过80-120目筛子,得到雪灵芝研磨粉;
(3)将鲜夏枯草、鲜猫眼草、鲜马齿苋、鲜小果蕗蕨、鲜女金芦分别清洗干净、打成泥,混合、搅拌均匀,得到鲜草泥;
(4)将维生素C、维生素E、异丁哌利福霉素、丙硫异烟胺片分别研磨成超微粉末,混合,过200-300目筛子,得到西药粉;
(5)将膏药基质加热至65-75℃,拌入雪灵芝渗漉粉、雪灵芝研磨粉、中药粉和西药粉,搅拌均匀,自然冷却至40-50℃,拌入羊胆膏和中药稠膏,搅拌均匀,再自然冷却至20-30℃,加入鲜草泥、尼泊金丙酯,搅拌均匀,得到膏药糊;
(6)将步骤(5)的膏药糊涂在无纺布上,并盖上PE膜,裁剪成需要的规格即可。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710162384.0A CN106822726A (zh) | 2017-03-18 | 2017-03-18 | 一种治疗淋巴结核的膏药及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710162384.0A CN106822726A (zh) | 2017-03-18 | 2017-03-18 | 一种治疗淋巴结核的膏药及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106822726A true CN106822726A (zh) | 2017-06-13 |
Family
ID=59144978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710162384.0A Pending CN106822726A (zh) | 2017-03-18 | 2017-03-18 | 一种治疗淋巴结核的膏药及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106822726A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109758511A (zh) * | 2019-01-30 | 2019-05-17 | 刘丹 | 一种中药组合物及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1231920A (zh) * | 1999-03-25 | 1999-10-20 | 韩振标 | 一种治疗淋巴结核药物的配方及其制作工艺 |
CN1326751A (zh) * | 2000-06-02 | 2001-12-19 | 赵康知 | 猫眼膏 |
CN101433662A (zh) * | 2007-11-15 | 2009-05-20 | 吴茂顺 | 二方快愈淋巴结核的方剂和炮制 |
-
2017
- 2017-03-18 CN CN201710162384.0A patent/CN106822726A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1231920A (zh) * | 1999-03-25 | 1999-10-20 | 韩振标 | 一种治疗淋巴结核药物的配方及其制作工艺 |
CN1326751A (zh) * | 2000-06-02 | 2001-12-19 | 赵康知 | 猫眼膏 |
CN101433662A (zh) * | 2007-11-15 | 2009-05-20 | 吴茂顺 | 二方快愈淋巴结核的方剂和炮制 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109758511A (zh) * | 2019-01-30 | 2019-05-17 | 刘丹 | 一种中药组合物及其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104524170B (zh) | 一种治疗风火牙痛的中药及其制备方法 | |
CN106822726A (zh) | 一种治疗淋巴结核的膏药及其制备方法 | |
CN102552737B (zh) | 一种快速有效止血中药酊剂 | |
CN104107376A (zh) | 一种外用消炎药组方与制作方法 | |
CN104013942A (zh) | 一种治疗冻疮的药物组合及其制备方法 | |
CN103055200B (zh) | 一种治疗风热型银屑病的中药组合物及其制备方法 | |
CN105616653A (zh) | 一种治疗痱子的中药组合物 | |
CN105560987A (zh) | 医治冻疮的中药组合物及制法 | |
CN105055661A (zh) | 用于治疗烫伤的组合物及其制备方法 | |
CN105250525A (zh) | 一种治疗糖尿病足的中药洗剂及其制备方法 | |
CN1141105C (zh) | 化癌药液 | |
CN104257986A (zh) | 一种治疗肾炎的中药 | |
CN104189608B (zh) | 一种治疗复发性口腔溃疡的中药制剂及制备方法 | |
CN108524869A (zh) | 一种强力抗癌的外用中草药制剂 | |
CN108066738B (zh) | 一种治疗痛风性关节炎的药膏及其制备方法 | |
CN102038928A (zh) | 用于治疗急慢性荨麻疹及皮肤病的中药 | |
CN106361999A (zh) | 一种治疗口腔癌喷雾及其制备方法 | |
CN104257931A (zh) | 骨科用跌打损伤外敷贴剂及制备方法 | |
CN104645196A (zh) | 一种治疗癌痛的中药配方 | |
CN104306772A (zh) | 一种治疗放射性皮炎的中药组合物及其制备方法 | |
CN1223121A (zh) | 一种治疗慢性溃疡性结肠炎的药物及其制备方法 | |
CN111298072A (zh) | 一种抗蝮蛇毒的中药组合物 | |
CN113288949A (zh) | 三制带状疱疹解毒散 | |
CN110960664A (zh) | 治疗癌症的中药组合物及其制备方法和应用 | |
CN107898834A (zh) | 一种抑制外伤的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170613 |
|
RJ01 | Rejection of invention patent application after publication |